260 related articles for article (PubMed ID: 9920507)
1. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S
Atherosclerosis; 1999 Jan; 142(1):67-77. PubMed ID: 9920507
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.
Kume S; Takeya M; Mori T; Araki N; Suzuki H; Horiuchi S; Kodama T; Miyauchi Y; Takahashi K
Am J Pathol; 1995 Sep; 147(3):654-67. PubMed ID: 7545874
[TBL] [Abstract][Full Text] [Related]
5. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
8. CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Xu S; Li L; Yan J; Ye F; Shao C; Sun Z; Bao Z; Dai Z; Zhu J; Jing L; Wang Z
Biomed Pharmacother; 2018 Jan; 97():1020-1031. PubMed ID: 29136780
[TBL] [Abstract][Full Text] [Related]
9. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.
Stitt AW; He C; Friedman S; Scher L; Rossi P; Ong L; Founds H; Li YM; Bucala R; Vlassara H
Mol Med; 1997 Sep; 3(9):617-27. PubMed ID: 9323713
[TBL] [Abstract][Full Text] [Related]
10. N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress.
Nerlich AG; Schleicher ED
Atherosclerosis; 1999 May; 144(1):41-7. PubMed ID: 10381276
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions.
Orekhov AN; Andreeva ER; Mikhailova IA; Gordon D
Atherosclerosis; 1998 Jul; 139(1):41-8. PubMed ID: 9699890
[TBL] [Abstract][Full Text] [Related]
12. Activation of tubular epithelial cells in diabetic nephropathy.
Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
[TBL] [Abstract][Full Text] [Related]
13. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.
Palinski W; Koschinsky T; Butler SW; Miller E; Vlassara H; Cerami A; Witztum JL
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):571-82. PubMed ID: 7749871
[TBL] [Abstract][Full Text] [Related]
14. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.
Makita Z; Yanagisawa K; Kuwajima S; Bucala R; Vlassara H; Koike T
Nephrol Dial Transplant; 1996; 11 Suppl 5():31-3. PubMed ID: 9044304
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.
Uesugi N; Sakata N; Nangaku M; Abe M; Horiuchi S; Hisano S; Iwasaki H
Am J Kidney Dis; 2004 Aug; 44(2):224-38. PubMed ID: 15264180
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
Li P; Tang Z; Wang L; Feng B
Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.
Kilhovd BK; Berg TJ; Birkeland KI; Thorsby P; Hanssen KF
Diabetes Care; 1999 Sep; 22(9):1543-8. PubMed ID: 10480523
[TBL] [Abstract][Full Text] [Related]
18. Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage.
Meng J; Sakata N; Imanaga Y; Takebayashi S; Nagai R; Horiuchi S
Nephron; 2001 May; 88(1):30-5. PubMed ID: 11340347
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products in diabetic nephropathy.
Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
